Press Release

Single Cell Genome Sequencing Market to Grow with a CAGR of 15.95% Globally through 2028

Increase in the incidence of chronic disease and increase in the aging population is expected to drive the Global Single Cell Genome Sequencing Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Single Cell Genome Sequencing Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Single Cell Genome Sequencing Market stood at USD 2.27 Billion in 2022 and is anticipated to grow with a CAGR of 15.95% in the forecast period, 2024-2028. The awareness among individuals regarding Single Cell Genome Sequencing has led to favorable market conditions for the global Single Cell Genome Sequencing market. Several factors contribute to the growth of various Single Cell Genome Sequencing products.

The use of single-cell genome sequencing in clinical and diagnostic applications is another significant driver. This technology has the potential to revolutionize personalized medicine by allowing the identification of specific genetic mutations and variations in individual cells. It is essential for diagnosing and monitoring diseases, understanding the development of cancer, and tailoring treatments to individual patients. The increasing demand for more accurate and personalized medical interventions is propelling the growth of this market.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Single Cell Genome Sequencing Market

 

Ongoing technological innovations in the field of genomics, particularly in the sequencing technologies and bioinformatics tools used for single-cell sequencing, are driving market growth. Advances in sequencing platforms, such as single-cell RNA sequencing, have made the process more efficient, cost-effective, and accessible. Additionally, improvements in data analysis and bioinformatics tools have enhanced the ability to extract meaningful insights from single-cell data, further fueling the adoption of single-cell genome sequencing.

In September 2023, Novogene announced that it has signed a strategic partnership agreement with the Chinese Academy of Sciences (CAS) to collaborate on the development and commercialization of new genomic technologies.

Increased investments and funding from government agencies, private sector companies, and research institutions have significantly contributed to the growth of the single-cell genome sequencing market. Funding supports research, development, and commercialization efforts, making technology more accessible and affordable. As governments and organizations recognize the potential of single-cell sequencing in various fields, they are allocating resources to advance its applications and capabilities.

In today's fast-paced world, single-cell genome sequencing allows for personalized treatment. By analyzing the unique genetic makeup of individual cells, it enables tailored medical interventions, ensuring that patients receive the most effective and targeted therapies. This minimizes trial-and-error in treatments, resulting in quicker recovery and better outcomes. Cancer is a rapidly progressing disease, and timely and accurate diagnosis is crucial. Single-cell genome sequencing helps in early cancer detection, monitors disease progression, and identifies genetic mutations linked to cancer. This is vital in making swift treatment decisions, including the use of targeted therapies. In the fast-paced pharmaceutical industry, single-cell sequencing accelerates drug development. It allows researchers to identify potential drug targets, evaluate drug efficacy at the single-cell level, and stratify patients for clinical trials. This speeds up the development and approval of new drugs. In the face of rapidly spreading infectious diseases, single-cell sequencing helps track pathogens and their mutations. This information is crucial for developing vaccines, antiviral drugs, and understanding how diseases evolve. Mental health is an urgent concern in today's world. Single-cell genome sequencing is used to study the genetic basis of neurological disorders. It provides insights into brain cell diversity and disease mechanisms, paving the way for quicker advancements in mental health treatment.

The growing genomic research has paved the way for emerging fields such as single-cell transcriptomics and epigenomics. Single-cell RNA sequencing, for instance, enables the measurement of gene expression at the single-cell level, providing insights into cellular function. Epigenomics explores epigenetic modifications that regulate gene expression and is vital for understanding how genes are turned on and off in individual cells.

In recent times, Single-cell genome sequencing is pivotal in the current era of personalized healthcare. It enables healthcare professionals to tailor treatments to an individual's unique genetic makeup. This results in more effective and targeted therapies, minimizing adverse effects and optimizing patient outcomes. Understanding the genetic variations within tumors is crucial in cancer research. Single-cell genome sequencing allows for a detailed analysis of cancer cell populations, helping researchers identify the genetic mutations responsible for tumor growth. This knowledge leads to the development of more effective cancer therapies. Early diagnosis is a cornerstone of modern healthcare. Single-cell sequencing is increasingly used in early disease detection, especially in cases like cancer, where identifying genetic abnormalities at the single-cell level can lead to early intervention and better prognosis. However, the Cost and Accessibility may hinder market growth. Moreover, challenges related to Data Integration and Interpretation and Regulatory and Ethical Considerations may pose obstacles to the Single Cell Genome Sequencing market in the near future.

The Global Single Cell Genome Sequencing Market is segmented into product type, technology, workflow, disease area, application, end-user, regional distribution, and company.

Based on its product, the Instruments segment has emerged as the predominant market leader, The development of advanced sequencing platforms, such as droplet-based systems and microfluidic technologies, has been a driving force in the Instruments segment's dominance. These platforms allow for the simultaneous sequencing of thousands of individual cells, making single-cell sequencing more efficient and cost-effective. Instruments that offer high throughput are in high demand, as they enable researchers to analyze a large number of cells in a shorter timeframe. This is crucial for comprehensive studies and large-scale projects, particularly in clinical and pharmaceutical research. Modern instruments are capable of handling multi-omics data from single cells, which is becoming increasingly important in genomics research. The ability to simultaneously analyze genomics, transcriptomics, epigenomics, and proteomics data from individual cells enhances the value of these instruments.

Based on region, North America segment is expected to grow during the forecast period.  The predominant position of North America can be ascribed to a range of factors. These encompass the growing prevalence of cancer and chronic diseases in the region, ongoing technological advancements, and substantial research and development initiatives by North American companies. Furthermore, the proliferation of genomic clinics in the area has further reinforced its leadership in the market.

The Asia-Pacific market is poised to be the fastest-growing market, offering lucrative growth opportunities for Single Cell Genome Sequencing players during the forecast period. Factors such as the key factors fueling growth is the expanding elderly population, which is resulting in a higher incidence of chronic illnesses among patients. Furthermore, the region is expected to experience notable improvements in healthcare infrastructure, driven by the endeavors of emerging nations to bolster their economies.

Major companies operating in Global Single Cell Genome Sequencing Market are:

  • Bio-Rad Laboratories Inc
  • 10x Genomics Inc
  • Novogene Co. Ltd
  • BGI Genomics Co Ltd.
  • Illumina, Inc.
  • Oxford Nanopore Technologies Plc
  • Pacific Biosciences Laboratories Inc
  • Thermo Fisher Scientific, Inc.
  • QIAGEN GmbH
  • F. Hoffmann-La-Roche Ltd

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The Advancements in Genomic Research and increasing Clinical and Diagnostic Applications are key drivers of the Single Cell Genome Sequencing market. In recent years, the Continuous improvement in sequencing platforms, sample preparation, and data analysis tools make single-cell genome sequencing more accessible, cost-effective, and accurate. Moreover, the growing consumer emphasis on preventative healthcare products has enhanced production and marketing efforts. To meet the demands of the market, manufacturers are increasingly incorporating cutting-edge technologies with high production efficiency. Rising consumer acceptance and continuous product innovation will further ensure the growth of the Single Cell Genome Sequencing market in the coming years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Global Single Cell Genome Sequencing Market – Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 Segmented By Product Type (Instruments, Reagents), By Technology (NGS, PCR, qPCR, Microarray, MDA), By Workflow (Genomic Analysis, Single Cell Isolation, Sample Preparation), By Disease Area (Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Others), By Application (Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization, Others), By End-User (Academic & Research Laboratories, Biotechnology & Biopharmaceutical Companies, Clinics, Others), By Region, Competition”, has evaluated the future growth potential of Global Single Cell Genome Sequencing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Single Cell Genome Sequencing Market.

 

Contact Us-

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News